SARS-CoV-2 Mpro-IN-38
SARS-CoV-2 Mpro-IN-38 (2-5a) is a SARS-CoV‑2 Mpro inhibitor, with an IC50 of 0.0435 μM[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV; Virus Protease
Related Pathways
Anti-infection
Field of Research
Infection; Inflammation/Immunology
Smiles
O=C(COC1=CC=CC2=C1C=CC=C2)N[C@H](C(N3C[C@H](C4(C)C)[C@H]4[C@H]3C(N[C@@H](C[C@H]5C(NCC5)=O)C#N)=O)=O)C(C)(C)C
Molecular Formula
C33H41N5O5
Molecular Weight
587.71
References & Citations
[1]Vishal K Singh, et al. Design, synthesis, and molecular dynamics simulation studies of quinoline derivatives as protease inhibitors against SARS-CoV-2. J Biomol Struct Dyn. 2022;40 (21) :10519-10542.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15119712 1 Vial
Lentiviral mouse Ccdc6 shRNA (UAS) - Lentiviral mouse Ccdc6 shRNA (UAS, RFP) (100)
Ask
View Details 
